Nov 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Therapeutics, Brown-Forman and Ulta Beauty on Friday.
HIGHLIGHTS
* Applied Therapeutics Inc : RBC cuts to sector perform from outperform
* Brown-Forman : Barclays cuts target price to $49 from $53
* Descartes Systems Group Inc : RBC raises target price to $133 from $115
* The J.M. Smucker Company : Barclays raises target price to $126 from $121
* Ulta Beauty Inc : Citigroup raises target price to $390 from $345
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Applied Therapeutics Inc : RBC cuts to sector perform from outperform
* Applied Therapeutics Inc : RBC cuts target price to $4 from $12
* Brown-Forman : Barclays cuts target price to $49 from $53
* CF Industries Holdings Inc : Berenberg raises target price to $74 from $69
* Descartes Systems Group Inc : RBC raises target price to $133 from $115
* Domo Inc : TD Cowen raises target price to $10 from $9
* Pfizer : Berenberg raises target price to $29 from $27
* Smurfit Westrock Plc : JP Morgan raises target price to $69 from $65
* Splash Beverage Group Inc : H.C. Wainwright cuts target price to $0.5 from $1
* The J.M. Smucker Company : Barclays raises target price to $126 from $121
* TXNM Energy : Barclays raises target price to $52 from $46
* Ulta Beauty Inc : Citigroup raises target price to $390 from $345
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。